445 related articles for article (PubMed ID: 12070009)
1. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.
Schnittger S; Schoch C; Dugas M; Kern W; Staib P; Wuchter C; Löffler H; Sauerland CM; Serve H; Büchner T; Haferlach T; Hiddemann W
Blood; 2002 Jul; 100(1):59-66. PubMed ID: 12070009
[TBL] [Abstract][Full Text] [Related]
2. FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
Schnittger S; Schoch C; Kern W; Hiddemann W; Haferlach T
Acta Haematol; 2004; 112(1-2):68-78. PubMed ID: 15179006
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi H; Naoe T; Nakano Y; Yokota S; Minami S; Miyawaki S; Asou N; Kuriyama K; Jinnai I; Shimazaki C; Akiyama H; Saito K; Oh H; Motoji T; Omoto E; Saito H; Ohno R; Ueda R
Blood; 1999 May; 93(9):3074-80. PubMed ID: 10216104
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF
Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839
[TBL] [Abstract][Full Text] [Related]
6. Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).
Kainz B; Heintel D; Marculescu R; Schwarzinger I; Sperr W; Le T; Weltermann A; Fonatsch C; Haas OA; Mannhalter C; Lechner K; Jaeger U
Hematol J; 2002; 3(6):283-9. PubMed ID: 12522450
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
8. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Kottaridis PD; Gale RE; Frew ME; Harrison G; Langabeer SE; Belton AA; Walker H; Wheatley K; Bowen DT; Burnett AK; Goldstone AH; Linch DC
Blood; 2001 Sep; 98(6):1752-9. PubMed ID: 11535508
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA
Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.
Fröhling S; Schlenk RF; Breitruck J; Benner A; Kreitmeier S; Tobis K; Döhner H; Döhner K;
Blood; 2002 Dec; 100(13):4372-80. PubMed ID: 12393388
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of FLT3 ITD and D835 mutations in AML patients.
Sheikhha MH; Awan A; Tobal K; Liu Yin JA
Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519
[TBL] [Abstract][Full Text] [Related]
12. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
[TBL] [Abstract][Full Text] [Related]
13. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.
Thiede C; Steudel C; Mohr B; Schaich M; Schäkel U; Platzbecker U; Wermke M; Bornhäuser M; Ritter M; Neubauer A; Ehninger G; Illmer T
Blood; 2002 Jun; 99(12):4326-35. PubMed ID: 12036858
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
[TBL] [Abstract][Full Text] [Related]
15. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.
Bowen DT; Frew ME; Hills R; Gale RE; Wheatley K; Groves MJ; Langabeer SE; Kottaridis PD; Moorman AV; Burnett AK; Linch DC
Blood; 2005 Sep; 106(6):2113-9. PubMed ID: 15951308
[TBL] [Abstract][Full Text] [Related]
16. Internal tandem duplications of Flt3 gene (Flt3/ITD) predicts a poor post-remission outcome in adult patients with acute non-promyelocytic leukemia.
Ciolli S; Vannucchi AM; Leoni F; Nozzoli C; Longo G; Salati A; Pancrazzi A; Bianchi L; Gigli F; Bosi A
Leuk Lymphoma; 2004 Jan; 45(1):73-8. PubMed ID: 15061200
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
18. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2001 Dec; 15(12):1848-51. PubMed ID: 11753604
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis.
Yanada M; Matsuo K; Suzuki T; Kiyoi H; Naoe T
Leukemia; 2005 Aug; 19(8):1345-9. PubMed ID: 15959528
[TBL] [Abstract][Full Text] [Related]
20. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.
Zwaan CM; Meshinchi S; Radich JP; Veerman AJ; Huismans DR; Munske L; Podleschny M; Hählen K; Pieters R; Zimmermann M; Reinhardt D; Harbott J; Creutzig U; Kaspers GJ; Griesinger F
Blood; 2003 Oct; 102(7):2387-94. PubMed ID: 12816873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]